Clinical Trials

The first clinical trial of a completely novel and unprecedented approach to modifying the progression of Alzheimer's disease has opened in London. The study is being conducted in the…
Read More...

Innovent Biologics announced that its IND application for IBI-188, a fully human anti-CD47 monoclonal antibody (mAb) drug candidate, has been approved by the US Food & Drug…
Read More...

Selexis SA and Hoba Therapeutics announced that they have entered into an agreement to advance the development of Hoba’s clinical candidate HB-086 (rhMeteorin) for the treatment of…
Read More...

Sarepta Therapeutics announced that the Food and Drug Administration (FDA) has lifted the clinical hold for the Company’s Duchenne muscular dystrophy (DMD) micro-dystrophin gene therapy…
Read More...

Gilead Sciences and Galapagos announced that the randomized, placebo-controlled Phase 2 TORTUGA study of filgotinib, an investigational, selective JAK1 inhibitor, achieved its primary…
Read More...

Thrombolytic Science, LLC (TSI) announced initiation of a Phase 2 clinical trial to confirm the efficacy and safety of its sequential dual-treatment regimen of low-dose tissue…
Read More...

SGS announced that it has successfully implemented advanced techniques for the collection and use of Peripheral Blood Mononuclear Cells (PBMCs) for early phase clinical trials at its…
Read More...

CRF Health announced that its TrialMax Slate solution has been selected by a US biotech company for a global Phase III prostate cancer study. The large-scale trial will involve up to…
Read More...

PolyActiva Pty Ltd, a clinical-stage Australian biotechnology company, has recently recruited first patients into its Phase I clinical study designed to show its glaucoma implant is…
Read More...

Pfizer Inc. announced that it is terminating two ongoing clinical studies evaluating domagrozumab (PF-06252616) for the treatment of Duchenne muscular dystrophy (DMD): a Phase 2 safety…
Read More...

Tolero Pharmaceuticals has entered into a clinical research collaboration with AbbVie, a research-based global biopharmaceutical company, exploring the potential of combination therapy…
Read More...

Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd. announced positive topline results from a Phase 3, randomized, double-blind, placebo-controlled study of…
Read More...

Novocure and US Oncology Research are collaborating on PANOVA-3, a phase 3 pivotal trial testing the efficacy of Tumor Treating Fields combined with nab-paclitaxel and gemcitabine in…
Read More...

Inovio Pharmaceuticals, Inc. announced that the first participant has been dosed with PENNVAX-GP in a randomized clinical trial that will evaluate its ability to drive remission of HIV…
Read More...

Izana Bioscience announced the initiation of a phase II proof-of-concept clinical study of namilumab in ankylosing spondylitis, a debilitating arthritic disease of the spine that…
Read More...

Seattle Children’s has opened a chimeric antigen receptor (CAR) T-cell immunotherapy trial for children and young adults with relapsed or refractory non-central nervous system…
Read More...

Bristol-Myers Squibb Company and Tsinghua University, have entered into a collaboration to discover therapeutic agents against novel targets for autoimmune diseases and cancers. The…
Read More...

Athenex announced that both Phase 3 studies, KX-AK-003 and KX-AK-004, had achieved their primary endpoint of 100% clearance of actinic keratosis (AK) lesions at Day 57 within the face…
Read More...

Q BioMed Inc. announced that it is extending its option agreement with Washington University in St. Louis. Under the agreement granting the exclusive right to license the technology, Q…
Read More...

Innovent Biologics announced that it has received Investigational New Drug (IND) approval from the China Food and Drug Administration (CFDA) to initiate clinical trials in China with…
Read More...